Davipharm, a member of Adamed Group

Davipharm is one of the leading domestic manufacturers of high-quality generic drugs. Established in 2004, and certified in 2006 with WHO-GMP, in 2014 Davipharm reached the first 100 registered products and started exporting its medicinal products to the Philippines and Cambodia. In November 2017, Adamed Pharma acquired 70 percent of shares in Davipharm, and in April 2023 the company acquired the remaining shares and became the only shareholder of Davipharm. Today, Davipharm is the eight biggest local pharmaceutical company on the prescription drug market. With US$60 million investment, out of which over US$10 million has been spent on the upgrade of Davipharm manufacturing plant in Binh Duong, know-how and technology transfer, upgrade of production standards to implement the EU-GMP and export development, Davipharm continues strengthening its market position.

At Davipharm, we invest in dynamic growth and innovation. But first of all, we invest in people. We employ over 400 employees in our factory in Binh Duong and HCMC Office, including a multinational team of experts. And we all share one common vision: to deliver high-quality products and services at affordable prices to elevate the image of made in Vietnam medicines, supplying products to local and international markets.